Assisted Reproductive Technology (ART) Market Size (2024 - 2029)

The assisted reproductive technology market is anticipated to experience significant growth over the forecast period, driven by increasing infertility rates due to factors such as late marriages, stressful lifestyles, and rising obesity. The market's expansion is further supported by the declining birth rates and the growing geriatric population worldwide. Additionally, the rising acceptance of same-sex marriages and single parenthood is expected to boost demand for ART techniques. Despite potential challenges posed by changing government regulations, socio-ethical concerns, and high costs, the market is poised for growth as it regains momentum post-pandemic.

Home Market Analysis Healthcare Research Device Drug Combination Research Diagnostics and Therapeutics Research Obstetrics and Gynecology Research Assisted Reproductive Technology Industry Market Size

Market Size of Assisted Reproductive Technology (ART) Industry

Assisted Reproductive Technology (ART) Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR (2024 - 2029) 7.50 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Assisted Reproductive Technology (ART) Market Major Players

*Disclaimer: Major Players sorted in no particular order

Assisted Reproductive Technology (ART) Market Analysis

The Assisted Reproductive Technology Market is expected to register a CAGR of 7.5% during the forecast period(2024-2029).

The global assisted reproductive technology (ART) market size is expected to register a CAGR of 7.5% during the forecast period.

  • The increased social and economic burden caused by the novel COVID-19 gradually became worrisome for the healthcare sector. Various research found that the novel coronavirus invades the target cell by binding to angiotensin-converting enzyme 2 (ACE2), which is widely expressed in the ovaries, uterus, vagina, and placenta. In addition, research studies have been published on the impact of the pandemic on the fertility rate. 
  • For instance, a research study published in the BMJ Open Journal in February 2021 stated that SARS-CoV-2 interrupts female fertility by regulating ACE2 and interfering with ART procedures. Hence, fertility treatments increased during the pandemic and affected the market growth considerably. With the declining COVID-19 cases and large-scale vaccination, the studied market is expected to regain its full potential over the forecast period.
  • Factors such as rising cases of infertility due to late marriages, stressful lifestyles, obesity, high junk food intake, smoking, alcoholism, and drug addiction are driving the adoption of ART.
  • For instance, according to the data published on female infertility in the National Library of Medicines in December 2022, globally, 11% of women who had a previous live birth were unable to have another, and 2% of women aged 20 to 44 were unable to have any live births at all. As per the above source, infertility rates are higher in Eastern Europe, North Africa, and the Middle East. Hence, owing to the higher infertility, the demand for ART techniques is expected to increase over the years and drive the growth of the market.
  • Further, the declining birth rate in different regions across the world and the rapid increase in the geriatric population are expected to have a significant impact on the ART market. For instance, according to the data update by Eurostat in April 2022, the crude birth rate (the number of live births per 1,000 persons) in the European Union is declining gradually, reaching 9.1 in recent years. Hence, the demand for ART technology is expected to grow over the forecast period, fueling the overall market growth.
  • In addition, the increasing number of single parents and awareness about same-sex marriages and assisted reproductive technologies are also expected to play a significant role in the growth of the ART market over the forecast period. For instance, according to the 2022 update of the Human Rights Campaign (HRC) Foundation, the number of countries where same-sex marriage is legal has increased to 32 in 2022, and parliamentary or court proceedings are underway in several countries, and this number is further expected to increase. Thus, with the increase in same-sex marriages, the demand for ART techniques is expected to increase significantly, which will boost growth in the studied market.
  • However, changing government regulations along with socio-ethical issues and high costs associated with ART are expected to restrain the growth of the assisted reproductive technologies (ART) market is expected to grow during the forecast period.

Assisted Reproductive Technology (ART) Industry Segmentation

Assisted reproductive technology (ART) is used to treat infertility. In vitro fertilization (IVF) is the most common and effective type of ART. Whereas multiple pregnancy condition is the most common complication associated with ART. 

The assisted reproductive technology (ART) market is segmented by technology (in vitro fertilization (IVF), artificial insemination (AI-IUI), frozen embryo replacement (FER), and others), end-users (hospital and fertility clinics), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. 

The report offers the value (in USD) for the above segments.

By Technology
In Vitro-fertilization (IVF)
Artificial Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Others
By End Users
Hospital
Fertility Clinics
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Assisted Reproductive Technology (ART) Market Size Summary

The assisted reproductive technology (ART) market is poised for significant growth, driven by increasing infertility rates due to factors such as late marriages, stressful lifestyles, and lifestyle-related health issues. The market is expected to expand steadily over the forecast period, with in vitro fertilization (IVF) emerging as a key segment due to its high success rates and advancements in technology. The COVID-19 pandemic initially disrupted the market but also led to a surge in fertility treatments, which is expected to contribute to the market's recovery and growth. The declining birth rates and the rising geriatric population further underscore the demand for ART, as does the growing acceptance and legal recognition of same-sex marriages, which has increased awareness and demand for these technologies.

North America is anticipated to hold a significant share of the global ART market, supported by a robust healthcare infrastructure and a high number of fertility clinics. The United States, in particular, is expected to be a major market due to the increasing infertility rates and the availability of comprehensive data on clinic success rates. The market is moderately competitive, with key players like Bloom IVF Centre, CooperSurgical Inc., and FUJIFILM Irvine Scientific, Inc. actively contributing to advancements and expansions in ART technologies. Regulatory initiatives and government support, such as the establishment of state-assisted reproductive technology boards, are also expected to bolster market growth by ensuring quality and accessibility of ART services.

Explore More

Assisted Reproductive Technology (ART) Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Number of Infertility Cases

      2. 1.2.2 Rise in Number of Single Women and Same-sex Couples

      3. 1.2.3 Increase in Awareness for IVF and Surrogacy

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost and Socio-ethical Issues

      2. 1.3.2 Changing Government Regulations

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD)

    1. 2.1 By Technology

      1. 2.1.1 In Vitro-fertilization (IVF)

      2. 2.1.2 Artificial Insemination (AI-IUI)

      3. 2.1.3 Frozen Embryo Replacement (FER)

      4. 2.1.4 Others

    2. 2.2 By End Users

      1. 2.2.1 Hospital

      2. 2.2.2 Fertility Clinics

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Assisted Reproductive Technology (ART) Market Size FAQs

The Assisted Reproductive Technology Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029)

CooperSurgical Inc., Hamilton Thorne Inc., Ferring B.V., FUJIFILM Irvine Scientific, Inc and Nidacon International AB are the major companies operating in the Assisted Reproductive Technology Market.

Assisted Reproductive Technology Market Report Snapshots

Assisted Reproductive Technology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)